July 19, 2024
Research Antibodies Market

The Global Research Antibodies Market Is Driven By Increasing Investments In R&D And High Demand For Personalized Medicine

Research antibodies are commonly used for various applications in life science research, drug development and medical diagnosis. They help identify cellular components by specifically binding to particular structures of interest within a cell or tissue. Different types of research antibodies including primary, secondary and recombinant antibodies are available for use in applications like ELISA, western blot, immunofluorescence and immunohistochemistry. Their specificity, high precision and minimal background noise achieved make them attractive tools for developing biopharmaceuticals and advancing healthcare. The growing awareness regarding chronic conditions and rising healthcare expenditure on developing targeted therapies have boosted the use of research antibodies protocols in academic as well as industrial research settings. The global Research Antibodies Market is estimated to be valued at US$ 3785.5 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the major trends in the research antibodies market is the increasing demand for monoclonal antibodies. Monoclonal antibodies are extensively used in research for selective targeting and to study protein functions in normal and disease conditions. As they can be custom-designed to detect specific molecules of interest, they find widespread acceptance across diverse therapeutic areas. Moreover, affinity maturation techniques allow enhancing monoclonal antibody affinity and selectivity, thereby addressing current research challenges. With ongoing advancements in antibody engineering and production methods, the monoclonal antibody segment is poised to witness strong growth over the coming years. Furthermore, investments towards development of bispecific and multifunctional monoclonal antibody therapeutics will drive innovation and widen the applications horizon in this domain

Porter’s Analysis

Threat of new entrants: The threat of new entrants in the research antibodies market is low due to high manufacturing cost, need for skilled labor and quality certifications required.
Bargaining power of buyers: The bargaining power of buyers is high as research antibodies are inputs used for further research and development activities. Buyers can negotiate for lower prices.
Bargaining power of suppliers: The bargaining power of suppliers is moderate due to presence of both global players as well as regional and local suppliers in the market.
Threat of new substitutes: There are limited substitutes available for research antibodies as they play a critical role in detection and quantification during research and development, thus threat from substitutes is low.
Competitive rivalry: The competitive rivalry in the research antibodies market is high due to presence of global and regional players competing on basis of product quality, pricing and innovation.

Key Takeaways

The global Research Antibodies Market Share is expected to witness high growth over the forecast period of 2023 to 2030. The market size for research antibodies was valued at US$ 3785.5 Bn in 2023.

Regional analysis: North America dominated the research antibodies market in 2023 with a share of over 35% owing to presence of major players and availability of funding for R&D activities in the region. Asia Pacific is anticipated to grow at the fastest pace during the forecast period supported by rising biotechnology industry in China and India.

Key players: Key players operating in the research antibodies market are Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, Cell Signalling Technology Inc., F.Hoffmann La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company, Agilent Technologies, Danaher Corporation, BioLegend Inc., Illumina, Phoenix Pharmaceuticals, Abcam plc. Thermo Fisher Scientific Inc is the market leader with wide portfolio of research antibodies.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it